US Patent 8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
Patent 8221786 was granted and assigned to Bristol-Myers Squibb on July, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.